Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease

被引：4

作者：

Shi Z. ^{[1
]}

Wu L. ^{[1
]}

Wang Y. ^{[1
]}

Zhang H. ^{[1
]}

Yang Y. ^{[1
]}

Hang C. ^{[1
]}

机构：

[1] Department of Neurosurgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Jiangsu Province, Nanjing

来源：

Chinese Neurosurgical Journal | / 9卷 / 1期

基金：

中国国家自然科学基金;

关键词：

Cerebral hyperperfusion syndrome; Clinical prognosis; Combined cerebral revascularization; Moyamoya disease; Risk factors;

D O I：

10.1186/s41016-023-00321-8

中图分类号：

学科分类号：

摘要：

Background: To investigate the incidence, risk factors, and clinical prognosis of cerebral hyperperfusion syndrome (CHS) after superficial temporal artery-middle cerebral artery anastomosis combined with encephalo-duro-arterio-synangiosis (STA-MCA/EDAS) in adult patients with moyamoya disease (MMD). Methods: The clinical data of 160 adult patients with MMD treated by STA-MCA/EDAS from January 2016 to January 2017 were retrospectively analyzed. According to CHS diagnosis, MMD patients were divided into CHS and non-CHS group. Univariate and multivariate analysis of risk factors and Kaplan-Meier curve of stroke-free survival for CHS were performed. Results: A total of 12 patients (7.5%) developed postoperative CHS, of which 4 patients (2.5%) presented with cerebral hemorrhage. Univariate and multivariate analysis showed moyamoya vessel on the surgical hemisphere (OR = 3.04, 95% CI = 1.02–9.03, P = 0.046) and left operated hemisphere (OR = 5.16, 95% CI = 1.09–21.34, P = 0.041) were independent risk factors for CHS. The other variables, such as age, gender, presentation, hypertension, diabetes, smoking, mean mRS score on admission, modified Suzuki stage and pre-infarction stage on surgical hemisphere, and bypass patency, had no association with postoperative CHS (P > 0.05). At final follow-up with average 38 months, there were 18 out of 133 patients (13.5%, 4.91% per person year) presented with newly developed complications. There was no significant difference between newly developed complications, mean mRS scores, and Kaplan-Meier curve of stroke-free survival in patients with and without CHS (P > 0.05). Conclusion: The concentration of moyamoya vessels and left operated hemisphere was independent risk factors for CHS, which could not affect the clinical prognosis if treated timely and properly. The current study offers a new perspective of moyamoya vessels and supporting data for choosing MMD candidates on cerebral revascularization. © 2023, The Author(s).

引用

共 42 条

[1]

Kuroda S., Houkin K., Moyamoya disease: current concepts and future perspectives, Lancet Neurol, 7, pp. 1056-1066, (2008)

[2]

Maki Y., Enomoto T., Moyamoya disease, Childs Nerv Syst, 4, pp. 204-212, (1988)

[3]

Fukuyama Y., Umezu R., Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (“moyamoya” disease) in children, Brain Dev, 7, pp. 21-37, (1985)

[4]

Han D.H., Nam D.H., Oh C.W., Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis, Clin Neurol Neurosurg, 99, pp. S151-S155, (1997)

[5]

Kurokawa T., Tomita S., Ueda K., Et al., Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children, Pediatr Neurol, 1, pp. 274-277, (1985)

[6]

Scott R.M., Smith E.R., Moyamoya disease and moyamoya syndrome, N Engl J Med, 360, pp. 1226-1237, (2009)

[7]

Fujimura M., Kaneta T., Mugikura S., Shimizu H., Tominaga T., Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease, Surg Neurol, 67, pp. 273-282, (2007)

[8]

Fujimura M., Shimizu H., Inoue T., Mugikura S., Saito A., Tominaga T., Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography, Neurosurgery, 68, pp. 957-964, (2011)

[9]

Fujimura M., Shimizu H., Mugikura S., Tominaga T., Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability, Surg Neurol, 71, pp. 223-227, (2009)

[10]

Kuroda S., Houkin K., Ishikawa T., Nakayama N., Iwasaki Y., Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome, Neurosurgery, 66, pp. 1093-1101, (2010)

← 1 2 3 4 5 →